Sandbox:UT: Difference between revisions
Jump to navigation
Jump to search
Tarek Nafee (talk | contribs) Created page with "__NOTOC__" |
Usama Talib (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
=Hypertriglyecridemia/Secondary Hypertriglyceridemia= | |||
==Classification== | |||
*As primary or secondary to another cause that can be [[obesity]], [[diabetes type 2]] or excessive alcohol consumption<ref name="pmid17420495">{{cite journal| author=Yuan G, Al-Shali KZ, Hegele RA| title=Hypertriglyceridemia: its etiology, effects and treatment. | journal=CMAJ | year= 2007 | volume= 176 | issue= 8 | pages= 1113-20 | pmid=17420495 | doi=10.1503/cmaj.060963 | pmc=1839776 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17420495 }} </ref> | |||
==Causes== | |||
===Secondary Hypertriglyceridemia=== | |||
* A diet high in carbohydrate content <ref name="pmid3330460">{{cite journal| author=Silva ME, Pupo AA, Ursich MJ| title=Effects of a high-carbohydrate diet on blood glucose, insulin and triglyceride levels in normal and obese subjects and in obese subjects with impaired glucose tolerance. | journal=Braz J Med Biol Res | year= 1987 | volume= 20 | issue= 3-4 | pages= 339-50 | pmid=3330460 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3330460 }} </ref> <ref name="pmid15504577">{{cite journal| author=McCarty MF| title=An elevation of triglycerides reflecting decreased triglyceride clearance may not be pathogenic -- relevance to high-carbohydrate diets. | journal=Med Hypotheses | year= 2004 | volume= 63 | issue= 6 | pages= 1065-73 | pmid=15504577 | doi=10.1016/j.mehy.2002.11.002 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15504577 }} </ref> | |||
* A diet high in fat content <ref name="pmid16672684">{{cite journal| author=Pejic RN, Lee DT| title=Hypertriglyceridemia. | journal=J Am Board Fam Med | year= 2006 | volume= 19 | issue= 3 | pages= 310-6 | pmid=16672684 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16672684 }} </ref> | |||
* Idiopathic | |||
* [[Obesity]] <ref name="pmid17420495">{{cite journal| author=Yuan G, Al-Shali KZ, Hegele RA| title=Hypertriglyceridemia: its etiology, effects and treatment. | journal=CMAJ | year= 2007 | volume= 176 | issue= 8 | pages= 1113-20 | pmid=17420495 | doi=10.1503/cmaj.060963 | pmc=1839776 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17420495 }} </ref> | |||
* Diabetes mellitus<ref name="pmid17420495">{{cite journal| author=Yuan G, Al-Shali KZ, Hegele RA| title=Hypertriglyceridemia: its etiology, effects and treatment. | journal=CMAJ | year= 2007 | volume= 176 | issue= 8 | pages= 1113-20 | pmid=17420495 | doi=10.1503/cmaj.060963 | pmc=1839776 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17420495 }} </ref> | |||
* [[Metabolic Syndrome]] <ref name="pmid11790215">{{cite journal| author=Ford ES, Giles WH, Dietz WH| title=Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. | journal=JAMA | year= 2002 | volume= 287 | issue= 3 | pages= 356-9 | pmid=11790215 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11790215 }} </ref> | |||
* Paraproteinemic disorders | |||
* Alcohol use <ref name="pmid17420495">{{cite journal| author=Yuan G, Al-Shali KZ, Hegele RA| title=Hypertriglyceridemia: its etiology, effects and treatment. | journal=CMAJ | year= 2007 | volume= 176 | issue= 8 | pages= 1113-20 | pmid=17420495 | doi=10.1503/cmaj.060963 | pmc=1839776 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17420495 }} </ref> | |||
* Estrogen therapy <ref name="pmid16672684">{{cite journal| author=Pejic RN, Lee DT| title=Hypertriglyceridemia. | journal=J Am Board Fam Med | year= 2006 | volume= 19 | issue= 3 | pages= 310-6 | pmid=16672684 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16672684 }} </ref> | |||
* Use of [[glucocorticoids]] <ref name="pmid16672684">{{cite journal| author=Pejic RN, Lee DT| title=Hypertriglyceridemia. | journal=J Am Board Fam Med | year= 2006 | volume= 19 | issue= 3 | pages= 310-6 | pmid=16672684 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16672684 }} </ref> | |||
* Medications like [[Zoloft]], [[isotretinoin]], some [[antihypertensive]] agents(e.g [[thiazides]]), [[tamoxifen]] <ref name="pmid16672684">{{cite journal| author=Pejic RN, Lee DT| title=Hypertriglyceridemia. | journal=J Am Board Fam Med | year= 2006 | volume= 19 | issue= 3 | pages= 310-6 | pmid=16672684 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16672684 }} </ref> | |||
* Nephrotic syndrome <ref name="pmid2002630">{{cite journal| author=Appel G| title=Lipid abnormalities in renal disease. | journal=Kidney Int | year= 1991 | volume= 39 | issue= 1 | pages= 169-83 | pmid=2002630 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2002630 }} </ref> | |||
==References== | |||
{{Reflist|2}} |
Revision as of 15:50, 8 November 2016
Hypertriglyecridemia/Secondary Hypertriglyceridemia
Classification
- As primary or secondary to another cause that can be obesity, diabetes type 2 or excessive alcohol consumption[1]
Causes
Secondary Hypertriglyceridemia
- A diet high in carbohydrate content [2] [3]
- A diet high in fat content [4]
- Idiopathic
- Obesity [1]
- Diabetes mellitus[1]
- Metabolic Syndrome [5]
- Paraproteinemic disorders
- Alcohol use [1]
- Estrogen therapy [4]
- Use of glucocorticoids [4]
- Medications like Zoloft, isotretinoin, some antihypertensive agents(e.g thiazides), tamoxifen [4]
- Nephrotic syndrome [6]
References
- ↑ 1.0 1.1 1.2 1.3 Yuan G, Al-Shali KZ, Hegele RA (2007). "Hypertriglyceridemia: its etiology, effects and treatment". CMAJ. 176 (8): 1113–20. doi:10.1503/cmaj.060963. PMC 1839776. PMID 17420495.
- ↑ Silva ME, Pupo AA, Ursich MJ (1987). "Effects of a high-carbohydrate diet on blood glucose, insulin and triglyceride levels in normal and obese subjects and in obese subjects with impaired glucose tolerance". Braz J Med Biol Res. 20 (3–4): 339–50. PMID 3330460.
- ↑ McCarty MF (2004). "An elevation of triglycerides reflecting decreased triglyceride clearance may not be pathogenic -- relevance to high-carbohydrate diets". Med Hypotheses. 63 (6): 1065–73. doi:10.1016/j.mehy.2002.11.002. PMID 15504577.
- ↑ 4.0 4.1 4.2 4.3 Pejic RN, Lee DT (2006). "Hypertriglyceridemia". J Am Board Fam Med. 19 (3): 310–6. PMID 16672684.
- ↑ Ford ES, Giles WH, Dietz WH (2002). "Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey". JAMA. 287 (3): 356–9. PMID 11790215.
- ↑ Appel G (1991). "Lipid abnormalities in renal disease". Kidney Int. 39 (1): 169–83. PMID 2002630.